Investing in Growth, Enabling Change
English      中文

Arsenal Capital Partners is a progressive private equity firm that
facilitates transformational growth and change through a
collaborative approach.

News

Royal Holdings, Inc., through its Kommerling UK Limited subsidiary, has acquired Chemical Innovations Limited from Vita (Group) Unlimited

Chemical Innovations Limited's high performance rubber to metal adhesives add a new technology to Royal's global adhesives & sealants product portfolio

South Bend, IN. April 2, 2015) — Royal Holdings, Inc. (Royal), a portfolio company of Arsenal Capital Partners (Arsenal), announced that it has through its Kommerling UK Limited subsidiary, acquired the stock of Chemical Innovations Limited (CIL) from Vita (Group) Unlimited.

Based in Preston, UK, CIL is a leading developer and manufacturer of high performance rubber to metal, rubber to plastic, rubber to fabric and rubber to glass bonding adhesives for high performance automotive and industrial applications, including anti-vibration, hoses and belting and...

Accella Performance Materials Announces Acquisition of IPS Polymer Systems, Inc.

Combines Best of Technologies, Manufacturing and Market Channel Access To Provide Added Value

St. Louis, MO – February 27, 2015 – Accella Performance Materials, Inc., (“Accella”, rebranded from Dash Multi-Corp, Inc.) a leading manufacturer of polyurethane systems and recycled rubber products, today announced the acquisition of IPS Polymer Systems, Inc. (“IPS”) in Rancho Cucamonga, CA. Accella is backed by Arsenal Capital Partners (“Arsenal Capital”).

(READ MORE)

Royal Adhesives & Sealants Acquires Advanced Polymers International

Acquisition Builds on Royal's Strong Position in the Specialty Label Market

SOUTH BEND, IN. January 9, 2015. Royal Adhesives & Sealants LLC (Royal) a portfolio company of Arsenal Capital Partners (Arsenal) announced today the completion of its acquisition of the assets of Advanced Polymers International (API) from PCI Paper Conversions, Inc. (PCI).

API, located in Syracuse, New York, is a manufacturer of microsphere based adhesives.  API's repositionable adhesives are designed for a wide variety of coating methods including: slot die, flexo, air knife, mayer rod, curtain, and gravure. 

API’s GelTac® microsphere...

Berkshire Hathaway Inc. Acquires Charter Brokerage

OMAHA, NE and NEW YORK, NY — December 12, 2014 — Berkshire Hathaway Inc. (NYSE: BRK.A and BRK.B) is acquiring Charter Brokerage, a leading non-asset based third party logistics provider to the petroleum and chemical industries, from Arsenal Capital Partners.

Warren Buffett, Chairman and CEO of Berkshire Hathaway said, “Charter Brokerage is a high quality business with consistently strong financial performance that fits well within Berkshire Hathaway.  We are delighted to partner with Bobby Waid, CEO, and its current management team.”

...

Accella Performance Materials Announces Sale of Specialty Assets to PolyOne Corporation

St. Louis, MO - Dec 1, 2014 – Accella Performance Materials, Inc. (Accella), a leading manufacturer of polyurethane systems and recycled rubber products, has announced the sale of specialty assets to PolyOne Corporation (NYSE: POL). The divested assets are not related to Accella’s polyurethanes and recycled rubber business, and are a strong fit with PolyOne’s Global Color, Additives and Inks segment. Accella was acquired in 2012 by Arsenal Capital Partners (Arsenal), a leading New York-based private equity firm that...

ePharmaSolutions Joins the WIRB-Copernicus Group

New Addition Expands WCG's eClinical Offerings for Improving Clinical Trial Start-Up and Management

PRINCETON, N.J., Sept. 24, 2014 – WIRB-Copernicus Group (WCG), the world's largest provider of regulatory and ethical review services for clinical research, announced today that ePharmaSolutions (ePS) has joined its group of companies. Based near Philadelphia, PA, ePS is a leading provider of eClinical solutions and technology-enabled services that improve the conduct of clinical trials. Its proprietary solutions, including a cloud-based enterprise Clinical Trial Portal (CTP) and Electronic Trial Master File (eTMF), are used...

Mouse over text to stop rotation
Copyright © 2005 - 2015 Arsenal Capital Partners. All rights reserved.